Optogenetic therapy improves light sensitivity in people with retinitis pigmentosa

Steadycorroborated5 outlets reported this themselves in 5 reports over 3 days - more reporting than echo.

Wed, 7 October 2026peak 3 reports on Thu, 8 October 2026Thu, 15 October 2026

What it is about

original reportfirst to report

Le Monde (France)

news-medical.net

ANSA (Italy)

Der Spiegel (Germany)

24sata (Croatia)

7 Oct, 21:10over 8 days15 Oct, 10:00

Wed, 7 October 2026
1 report
- Le Monde (France)21:10first to report
  Un traitement optogénétique redonne une vision partielle à six patients aveugles
  Un essai clinique, mené chez dix personnes non voyantes en France, aux Etats-Unis et au Royaume-Uni, suggère l’intérêt, pour restaurer une forme de vision, d’un traitement qui consiste à injecter dans l’œil un vecteur viral porteur d’une construction génétique.
Thu, 8 October 2026
3 reports
- news-medical.net03:09
  Optogenetic therapy improves light sensitivity in people with retinitis pigmentosa
  An international research team has reported new results from the first clinical cohort of blind people treated with an optogenetic therapy for advanced retinitis pigmentosa.
- ANSA (Italy)08:00
  Dall'optogenetica primi risultati su una malattia della retina
  Segni di ripristino della vista in 10 persone
- Der Spiegel (Germany)16:12
  Blinde: Optogenetik-Therapie gilt laut Studie als sicher
  Ein Team aus Basel meldet einen Erfolg für die Gentherapie einer seltenen Augenkrankheit. Die Erforschung der Grundlagen wurde gerade mit dem Nobelpreis gewürdigt.
Thu, 15 October 2026
1 report
- 24sata (Croatia)10:00
  Revolucija u medicini: Nova terapija vraća vid pacijentima!
  Riječ je o terapiji koja budi velike nade, a u primjeni se može očekivati za 10 do 15 godina, kažu prof. dr. sc. Nataša Drača i dr. Emma Grace Orešković iz Specijalne bolnica za oftalmologiju Svjetlost